BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17317952)

  • 1. Exclusion of serum- and glucocorticoid-induced kinase 1 (SGK1) as a candidate gene for genetically heterogeneous renal pseudohypoaldosteronism type I in eight families.
    Riepe FG; Holterhus PM
    Am J Nephrol; 2007; 27(2):164-9. PubMed ID: 17317952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and molecular features of type 1 pseudohypoaldosteronism.
    Riepe FG
    Horm Res; 2009; 72(1):1-9. PubMed ID: 19571553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I.
    Geller DS; Rodriguez-Soriano J; Vallo Boado A; Schifter S; Bayer M; Chang SS; Lifton RP
    Nat Genet; 1998 Jul; 19(3):279-81. PubMed ID: 9662404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism.
    Pujo L; Fagart J; Gary F; Papadimitriou DT; Claës A; Jeunemaître X; Zennaro MC
    Hum Mutat; 2007 Jan; 28(1):33-40. PubMed ID: 16972228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidating the underlying molecular pathogenesis of NR3C2 mutants causing autosomal dominant pseudohypoaldosteronism type 1.
    Riepe FG; Finkeldei J; de Sanctis L; Einaudi S; Testa A; Karges B; Peter M; Viemann M; Grötzinger J; Sippell WG; Fejes-Toth G; Krone N
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4552-61. PubMed ID: 16954160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revealing a subclinical salt-losing phenotype in heterozygous carriers of the novel S562P mutation in the alpha subunit of the epithelial sodium channel.
    Riepe FG; van Bemmelen MX; Cachat F; Plendl H; Gautschi I; Krone N; Holterhus PM; Theintz G; Schild L
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):252-8. PubMed ID: 18547339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for genetic heterogeneity of pseudohypoaldosteronism type 1: identification of a novel mutation in the human mineralocorticoid receptor in one sporadic case and no mutations in two autosomal dominant kindreds.
    Viemann M; Peter M; López-Siguero JP; Simic-Schleicher G; Sippell WG
    J Clin Endocrinol Metab; 2001 May; 86(5):2056-9. PubMed ID: 11344206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five novel mutations in the SCNN1A gene causing autosomal recessive pseudohypoaldosteronism type 1.
    Welzel M; Akin L; Büscher A; Güran T; Hauffa BP; Högler W; Leonards J; Karges B; Kentrup H; Kirel B; Senses EE; Tekin N; Holterhus PM; Riepe FG
    Eur J Endocrinol; 2013 May; 168(5):707-15. PubMed ID: 23416952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic diversity and correlation with the genotypes of pseudohypoaldosteronism type 1.
    Gopal-Kothandapani JS; Doshi AB; Smith K; Christian M; Mushtaq T; Banerjee I; Padidela R; Ramakrishnan R; Owen C; Cheetham T; Dimitri P
    J Pediatr Endocrinol Metab; 2019 Sep; 32(9):959-967. PubMed ID: 31301676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudohypoaldosteronisms, report on a 10-patient series.
    Belot A; Ranchin B; Fichtner C; Pujo L; Rossier BC; Liutkus A; Morlat C; Nicolino M; Zennaro MC; Cochat P
    Nephrol Dial Transplant; 2008 May; 23(5):1636-41. PubMed ID: 18424465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel splice site mutation of the beta subunit gene of epithelial sodium channel (ENaC) in one Turkish patient with a systemic form of pseudohypoaldosteronism Type 1.
    Dogan CS; Erdem D; Mesut P; Merve A; Sema A; Iffet B; Afig B
    J Pediatr Endocrinol Metab; 2012; 25(9-10):1035-9. PubMed ID: 23426840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid receptor mutations differentially affect individual gene expression profiles in pseudohypoaldosteronism type 1.
    Fernandes-Rosa FL; Hubert EL; Fagart J; Tchitchek N; Gomes D; Jouanno E; Benecke A; Rafestin-Oblin ME; Jeunemaitre X; Antonini SR; Zennaro MC
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E519-27. PubMed ID: 21159846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence of the R947X mutation in unrelated families with autosomal dominant pseudohypoaldosteronism type 1: evidence for a mutational hot spot in the mineralocorticoid receptor gene.
    Fernandes-Rosa FL; de Castro M; Latronico AC; Sippell WG; Riepe FG; Antonini SR
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3671-5. PubMed ID: 16757525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel SCNN1A gene splicing-site mutation causing autosomal recessive pseudohypoaldosteronism type 1 (PHA1) in two Italian patients belonging to the same small town.
    Serra G; Antona V; D'Alessandro MM; Maggio MC; Verde V; Corsello G
    Ital J Pediatr; 2021 Jun; 47(1):138. PubMed ID: 34134742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel splice-site mutation in the gamma subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families.
    Strautnieks SS; Thompson RJ; Gardiner RM; Chung E
    Nat Genet; 1996 Jun; 13(2):248-50. PubMed ID: 8640238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineralocorticoid resistance.
    Zennaro MC; Lombès M
    Trends Endocrinol Metab; 2004 Aug; 15(6):264-70. PubMed ID: 15358279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1.
    Tajima T; Kitagawa H; Yokoya S; Tachibana K; Adachi M; Nakae J; Suwa S; Katoh S; Fujieda K
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4690-4. PubMed ID: 11134129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mutations in the SCNN1A gene causing Pseudohypoaldosteronism type 1.
    Wang J; Yu T; Yin L; Li J; Yu L; Shen Y; Yu Y; Shen Y; Fu Q
    PLoS One; 2013; 8(6):e65676. PubMed ID: 23762408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel nonsense mutation of the mineralocorticoid receptor gene in a Swedish family with pseudohypoaldosteronism type I (PHA1).
    Nyström AM; Bondeson ML; Skanke N; Mårtensson J; Strömberg B; Gustafsson J; Annerén G
    J Clin Endocrinol Metab; 2004 Jan; 89(1):227-31. PubMed ID: 14715854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutations in epithelial sodium channel (ENaC) subunit genes and phenotypic expression of multisystem pseudohypoaldosteronism.
    Edelheit O; Hanukoglu I; Gizewska M; Kandemir N; Tenenbaum-Rakover Y; Yurdakök M; Zajaczek S; Hanukoglu A
    Clin Endocrinol (Oxf); 2005 May; 62(5):547-53. PubMed ID: 15853823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.